Healveda Care, a pioneering company dedicated to providing intelligent autoimmune solutions, has been awarded 1st place at the Stanford Graduate School of Business (GSB) Pitchfest, hosted by the prestigious GSB LISA program. Competing against 20 other startup companies, Healveda Care stood out with its transformative vision for improving outcomes for Autoimmune Conditions.

The Stanford GSB LISA program is an intensive 10-week leadership and entrepreneurship initiative designed to guide startups from a Minimum Viable Product (MVP) to scalable business models. Healveda Care thrived in this demanding environment, demonstrating exceptional progress and clear value proposition for the autoimmune community.

Through extensive market research and interviews, Healveda Care successfully generated a thriving community of 10,000 people affected by chronic illness, cultivated interest from 200 potential buyers, and gained the support of 40 industry experts. This achievement reflects the company’s deep understanding of the needs of the autoimmune community and its commitment to offering impactful solutions.

One of the significant milestones of the program was refining the pitch delivery — Healveda Care improved its pitch time from 47 minutes to a concise and compelling 3 minutes, showcasing their capacity to convey their mission with clarity and impact.

“We are honored to receive this recognition from the Stanford GSB Ventures program,” said Sweta Patel, CEO of Healveda Care. “Our journey is about more than just business; it’s about creating a non-judgmental space that supports, acknowledges and uplifts those battling Autoimmune Conditions. Winning this award strengthens our commitment to continue our mission of transforming lives through innovative healing solutions.”

The success at Stanford GSB Pitchfest is a testament to Healveda Care’s dedication to empowering individuals with autoimmune conditions by providing education, community, and accessible health solutions. As the company prepares for its next phase of growth, it remains steadfast in its mission to bring intelligent, evidence-based healing to those in need.